Formalin treatment for intractable hemorrhagic cystitis: a review of the literature with 16 additional cases.
Acute, exsanguinating hemorrhagic cystitis secondary to cyclophosphamide therapy, radiation therapy, or an infiltrating bladder tumor may be managed successfully with intravesical Formalin therapy. The indications for its use, the technique, success rates, and complications are discussed. This treatment was effective in 14 of 16 patients in the present series and 79 of 90 cases reported in the literature. Dilutions of 4% or less were as effective as a 10% dilution and were associated with far fewer complications. The early use of Formalin in the treatment of intractable hemorrhagic cystitis is recommended.
D000328:Adult; D002648:Child; D003520:Cyclophosphamide / Q000009:adverse effects; D003556:Cystitis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D005557:Formaldehyde / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D011878:Radiotherapy / Q000009:adverse effects; D007507:Therapeutic Irrigation; D001749:Urinary Bladder Neoplasms / Q000150:complications; D014546:Urinary Catheterization; D014718:Vesico-Ureteral Reflux / Q000150:complications
D005557:Formaldehyde; D003520:Cyclophosphamide